152. New Vaccines: Friday, 12:15 - 1:30 p.m.
Poster Session: New Vaccines
Gonzalo Pérez Marc, M.D.
Hospital Militar Central de Buenos Aires
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Edward E. Walsh, MD (he/him/his)
Professor of Medicine
University of Rochester
Rochester, NY, United States
Elliot N. DeHaan, MD
Associate Director
Pfizer
Pearly River, New York, United States
Conrado J. Llapur, MD
Hospital del Niño Jesús
San Miguel de Tucuman, Tucuman, Argentina
Agnieszka Zareba, MD PhD
Director Vaccines Research
Pfizer
Pearl RIver, New York, United States
Qin Jiang, PhD
Senior Director
Pfizer
Collegeville, Pennsylvania, United States
Kumar Ilangovan, MD, MSPH, MMCi (he/him/his)
Director, Clinician Medical Monitor
Vaccine Research and Development, Pfizer, USA
Raleigh, North Carolina, United States
John Woodside, PhD
Pfizer
London, England, United Kingdom
Daniel P. Eiras, MD, MPH
Associate Director
Pfizer, Inc.
Pearl River, New York, United States
Tarek Mikati, MD,MPH
Associate Medical Director
3. Pfizer, Inc., Vaccine Research & Development
Pearl River, New York, United States
Elena Kalinina, PhD
Director
Pfizer
Pearl River, New York, United States
David Cooper, PhD
Senior Director
Pfizer
Pearl River, New York, United States
Annaliesa S. Anderson, PhD
SVP & CSO
Pfizer
New York, New York, United States
Kena A. Swanson, Ph.D.
Vice President, Viral Vaccines
Pfizer
Pearl River, New York, United States
William C. Gruber, MD
SVP
Pfizer
Pearl River, New York, United States
Alejandra C. Gurtman, M.D.
Vice President
Pfizer
Pearl River, New York, United States
Beate Schmoele-Thoma, MD
Dr.
Pfizer
Pearl River, New York, United States